private:indeelabs
|
10222441
|
Apr 21st, 2024 12:00AM
|
Indee Labs
|
1.3K
|
7.00
|
Open
|
|
Apr 21st, 2024 06:30AM
|
Apr 21st, 2024 06:30AM
|
Indee Labs is a biotechnology startup backed by SOSV, Y Combinator, Social Capital and Founders Fund. The team at Indee Labs develops and markets Hydropore for more effective engineered cell therapies.
Indee Lab’s non-viral delivery platform, Hydropore, is a robust solution that overcomes the limitations and costs of electroporation, viral transduction, and other non-viral transfection methods. Hydropore is being developed in collaboration with 3 of the top 10 pharmaceutical companies, various biotechs and leading research institutions including UC San Francisco, Stanford, Medical University of South Carolina, the National Cancer Institute and the National Institute of Allergy and Infectious Disease among others.
|
Open
|
Gene Therapy, Cell-derived Gene Therapy, Microfluidics, Biotechnology, Medical Devices, Transfection, T Cell Manufacturing, Immunotherapy, T Cell Immunotherapy, Gene Editing, Genetic Engineering, Non-Viral Delivery, Cellular Engineering, and Intracellular Delivery
|
Open
|
626 Bancroft Way
|
Berkeley
|
California
|
US
|
94710
|
|
indee labs
|
|
|
private:indeelabs
|
10222441
|
Apr 20th, 2024 12:00AM
|
Indee Labs
|
1.3K
|
7.00
|
Open
|
|
Apr 20th, 2024 05:29AM
|
Apr 20th, 2024 08:47PM
|
Indee Labs is a biotechnology startup backed by SOSV, Y Combinator, Social Capital and Founders Fund. The team at Indee Labs develops and markets Hydropore for more effective engineered cell therapies.
Indee Lab’s non-viral delivery platform, Hydropore, is a robust solution that overcomes the limitations and costs of electroporation, viral transduction, and other non-viral transfection methods. Hydropore is being developed in collaboration with 3 of the top 10 pharmaceutical companies, various biotechs and leading research institutions including UC San Francisco, Stanford, Medical University of South Carolina, the National Cancer Institute and the National Institute of Allergy and Infectious Disease among others.
|
Open
|
Gene Therapy, Cell-derived Gene Therapy, Microfluidics, Biotechnology, Medical Devices, Transfection, T Cell Manufacturing, Immunotherapy, T Cell Immunotherapy, Gene Editing, Genetic Engineering, Non-Viral Delivery, Cellular Engineering, and Intracellular Delivery
|
Open
|
626 Bancroft Way
|
Berkeley
|
California
|
US
|
94710
|
|
indee labs
|
|
|
private:indeelabs
|
10222441
|
Apr 19th, 2024 12:00AM
|
Indee Labs
|
1.3K
|
7.00
|
Open
|
|
Apr 19th, 2024 07:55AM
|
Apr 19th, 2024 07:55AM
|
Indee Labs is a biotechnology startup backed by SOSV, Y Combinator, Social Capital and Founders Fund. The team at Indee Labs develops and markets Hydropore for more effective engineered cell therapies.
Indee Lab’s non-viral delivery platform, Hydropore, is a robust solution that overcomes the limitations and costs of electroporation, viral transduction, and other non-viral transfection methods. Hydropore is being developed in collaboration with 3 of the top 10 pharmaceutical companies, various biotechs and leading research institutions including UC San Francisco, Stanford, Medical University of South Carolina, the National Cancer Institute and the National Institute of Allergy and Infectious Disease among others.
|
Open
|
Gene Therapy, Cell-derived Gene Therapy, Microfluidics, Biotechnology, Medical Devices, Transfection, T Cell Manufacturing, Immunotherapy, T Cell Immunotherapy, Gene Editing, Genetic Engineering, Non-Viral Delivery, Cellular Engineering, and Intracellular Delivery
|
Open
|
626 Bancroft Way
|
Berkeley
|
California
|
US
|
94710
|
|
indee labs
|
|
|
private:indeelabs
|
10222441
|
Apr 18th, 2024 12:00AM
|
Indee Labs
|
1.3K
|
7.00
|
Open
|
|
Apr 18th, 2024 06:35AM
|
Apr 18th, 2024 10:08PM
|
Indee Labs is a biotechnology startup backed by SOSV, Y Combinator, Social Capital and Founders Fund. The team at Indee Labs develops and markets Hydropore for more effective engineered cell therapies.
Indee Lab’s non-viral delivery platform, Hydropore, is a robust solution that overcomes the limitations and costs of electroporation, viral transduction, and other non-viral transfection methods. Hydropore is being developed in collaboration with 3 of the top 10 pharmaceutical companies, various biotechs and leading research institutions including UC San Francisco, Stanford, Medical University of South Carolina, the National Cancer Institute and the National Institute of Allergy and Infectious Disease among others.
|
Open
|
Gene Therapy, Cell-derived Gene Therapy, Microfluidics, Biotechnology, Medical Devices, Transfection, T Cell Manufacturing, Immunotherapy, T Cell Immunotherapy, Gene Editing, Genetic Engineering, Non-Viral Delivery, Cellular Engineering, and Intracellular Delivery
|
Open
|
626 Bancroft Way
|
Berkeley
|
California
|
US
|
94710
|
|
indee labs
|
|
|
private:indeelabs
|
10222441
|
Apr 17th, 2024 12:00AM
|
Indee Labs
|
1.3K
|
7.00
|
Open
|
|
Apr 17th, 2024 07:55AM
|
Apr 17th, 2024 06:35PM
|
Indee Labs is a biotechnology startup backed by SOSV, Y Combinator, Social Capital and Founders Fund. The team at Indee Labs develops and markets Hydropore for more effective engineered cell therapies.
Indee Lab’s non-viral delivery platform, Hydropore, is a robust solution that overcomes the limitations and costs of electroporation, viral transduction, and other non-viral transfection methods. Hydropore is being developed in collaboration with 3 of the top 10 pharmaceutical companies, various biotechs and leading research institutions including UC San Francisco, Stanford, Medical University of South Carolina, the National Cancer Institute and the National Institute of Allergy and Infectious Disease among others.
|
Open
|
Gene Therapy, Cell-derived Gene Therapy, Microfluidics, Biotechnology, Medical Devices, Transfection, T Cell Manufacturing, Immunotherapy, T Cell Immunotherapy, Gene Editing, Genetic Engineering, Non-Viral Delivery, Cellular Engineering, and Intracellular Delivery
|
Open
|
626 Bancroft Way
|
Berkeley
|
California
|
US
|
94710
|
|
indee labs
|
|
|
private:indeelabs
|
10222441
|
Apr 16th, 2024 12:00AM
|
Indee Labs
|
1.3K
|
7.00
|
Open
|
|
Apr 16th, 2024 05:24AM
|
Apr 16th, 2024 02:53PM
|
Indee Labs is a biotechnology startup backed by SOSV, Y Combinator, Social Capital and Founders Fund. The team at Indee Labs develops and markets Hydropore for more effective engineered cell therapies.
Indee Lab’s non-viral delivery platform, Hydropore, is a robust solution that overcomes the limitations and costs of electroporation, viral transduction, and other non-viral transfection methods. Hydropore is being developed in collaboration with 3 of the top 10 pharmaceutical companies, various biotechs and leading research institutions including UC San Francisco, Stanford, Medical University of South Carolina, the National Cancer Institute and the National Institute of Allergy and Infectious Disease among others.
|
Open
|
Gene Therapy, Cell-derived Gene Therapy, Microfluidics, Biotechnology, Medical Devices, Transfection, T Cell Manufacturing, Immunotherapy, T Cell Immunotherapy, Gene Editing, Genetic Engineering, Non-Viral Delivery, Cellular Engineering, and Intracellular Delivery
|
Open
|
626 Bancroft Way
|
Berkeley
|
California
|
US
|
94710
|
|
indee labs
|
|
|
private:indeelabs
|
10222441
|
Apr 15th, 2024 12:00AM
|
Indee Labs
|
1.3K
|
7.00
|
Open
|
|
Apr 15th, 2024 08:15AM
|
Apr 15th, 2024 08:33PM
|
Indee Labs is a biotechnology startup backed by SOSV, Y Combinator, Social Capital and Founders Fund. The team at Indee Labs develops and markets Hydropore for more effective engineered cell therapies.
Indee Lab’s non-viral delivery platform, Hydropore, is a robust solution that overcomes the limitations and costs of electroporation, viral transduction, and other non-viral transfection methods. Hydropore is being developed in collaboration with 3 of the top 10 pharmaceutical companies, various biotechs and leading research institutions including UC San Francisco, Stanford, Medical University of South Carolina, the National Cancer Institute and the National Institute of Allergy and Infectious Disease among others.
|
Open
|
Gene Therapy, Cell-derived Gene Therapy, Microfluidics, Biotechnology, Medical Devices, Transfection, T Cell Manufacturing, Immunotherapy, T Cell Immunotherapy, Gene Editing, Genetic Engineering, Non-Viral Delivery, Cellular Engineering, and Intracellular Delivery
|
Open
|
626 Bancroft Way
|
Berkeley
|
California
|
US
|
94710
|
|
indee labs
|
|
|
private:indeelabs
|
10222441
|
Apr 14th, 2024 12:00AM
|
Indee Labs
|
1.3K
|
7.00
|
Open
|
|
Apr 14th, 2024 04:14AM
|
Apr 14th, 2024 04:14AM
|
Indee Labs is a biotechnology startup backed by SOSV, Y Combinator, Social Capital and Founders Fund. The team at Indee Labs develops and markets Hydropore for more effective engineered cell therapies.
Indee Lab’s non-viral delivery platform, Hydropore, is a robust solution that overcomes the limitations and costs of electroporation, viral transduction, and other non-viral transfection methods. Hydropore is being developed in collaboration with 3 of the top 10 pharmaceutical companies, various biotechs and leading research institutions including UC San Francisco, Stanford, Medical University of South Carolina, the National Cancer Institute and the National Institute of Allergy and Infectious Disease among others.
|
Open
|
Gene Therapy, Cell-derived Gene Therapy, Microfluidics, Biotechnology, Medical Devices, Transfection, T Cell Manufacturing, Immunotherapy, T Cell Immunotherapy, Gene Editing, Genetic Engineering, Non-Viral Delivery, Cellular Engineering, and Intracellular Delivery
|
Open
|
626 Bancroft Way
|
Berkeley
|
California
|
US
|
94710
|
|
indee labs
|
|
|
private:indeelabs
|
10222441
|
Apr 13th, 2024 12:00AM
|
Indee Labs
|
1.3K
|
7.00
|
Open
|
|
Apr 13th, 2024 03:09AM
|
Apr 13th, 2024 03:16PM
|
Indee Labs is a biotechnology startup backed by SOSV, Y Combinator, Social Capital and Founders Fund. The team at Indee Labs develops and markets Hydropore for more effective engineered cell therapies.
Indee Lab’s non-viral delivery platform, Hydropore, is a robust solution that overcomes the limitations and costs of electroporation, viral transduction, and other non-viral transfection methods. Hydropore is being developed in collaboration with 3 of the top 10 pharmaceutical companies, various biotechs and leading research institutions including UC San Francisco, Stanford, Medical University of South Carolina, the National Cancer Institute and the National Institute of Allergy and Infectious Disease among others.
|
Open
|
Gene Therapy, Cell-derived Gene Therapy, Microfluidics, Biotechnology, Medical Devices, Transfection, T Cell Manufacturing, Immunotherapy, T Cell Immunotherapy, Gene Editing, Genetic Engineering, Non-Viral Delivery, Cellular Engineering, and Intracellular Delivery
|
Open
|
626 Bancroft Way
|
Berkeley
|
California
|
US
|
94710
|
|
indee labs
|
|
|
private:indeelabs
|
10222441
|
Apr 12th, 2024 12:00AM
|
Indee Labs
|
1.3K
|
7.00
|
Open
|
|
Apr 12th, 2024 03:21AM
|
Apr 12th, 2024 12:22PM
|
Indee Labs is a biotechnology startup backed by SOSV, Y Combinator, Social Capital and Founders Fund. The team at Indee Labs develops and markets Hydropore for more effective engineered cell therapies.
Indee Lab’s non-viral delivery platform, Hydropore, is a robust solution that overcomes the limitations and costs of electroporation, viral transduction, and other non-viral transfection methods. Hydropore is being developed in collaboration with 3 of the top 10 pharmaceutical companies, various biotechs and leading research institutions including UC San Francisco, Stanford, Medical University of South Carolina, the National Cancer Institute and the National Institute of Allergy and Infectious Disease among others.
|
Open
|
Gene Therapy, Cell-derived Gene Therapy, Microfluidics, Biotechnology, Medical Devices, Transfection, T Cell Manufacturing, Immunotherapy, T Cell Immunotherapy, Gene Editing, Genetic Engineering, Non-Viral Delivery, Cellular Engineering, and Intracellular Delivery
|
Open
|
626 Bancroft Way
|
Berkeley
|
California
|
US
|
94710
|
|
indee labs
|
|
|